Rhumbline Advisers Merrimack Pharmaceuticals Inc Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Merrimack Pharmaceuticals Inc stock. As of the latest transaction made, Rhumbline Advisers holds 2,480 shares of MACK stock, worth $37,522. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,480
Previous 13,519
81.66%
Holding current value
$37,522
Previous $199,000
81.41%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MACK
# of Institutions
12Shares Held
437KCall Options Held
0Put Options Held
0-
Dimensional Fund Advisors LP Austin, TX319KShares$4.83 Million0.0% of portfolio
-
Jbf Capital, Inc. Aspen, CO39.6KShares$599,7070.1% of portfolio
-
Marshall Wace, LLP London, X038.2KShares$578,2830.0% of portfolio
-
Goldman Sachs Group Inc New York, NY29.8KShares$450,9790.0% of portfolio
-
Caldwell Sutter Capital, Inc. Sausalito, CA7.46KShares$112,8390.0% of portfolio
About MERRIMACK PHARMACEUTICALS INC
- Ticker MACK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,410,200
- Market Cap $203M
- Description
- Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.